John Moore is an experienced executive with a diverse background in leadership roles across various industries. He currently serves on the boards of two private companies and three public companies. Recently, John became a Director of Phase Holographic, a company specializing in live cell imaging systems for life science researchers. Phase Holographic's stock is traded on the Swedish Spotlight market and will soon be listed on the OTCQB market in the USA.

John will transition from his role as Chairman of Cormetech to being a shareholder and Director. He remains the Chairman of Scientific Industries (SCNDOTCQB), a producer of laboratory instruments for the life sciences industry, and Trialogics, a clinical trial informatics business.

John's prior experience includes serving as CEO of Acorn Energy from 2006 to 2015. During his tenure, the CoaLogix business was acquired for US$11 million and later sold for US$101 million. Additionally, the Comverge business was listed in the US before being sold to Constellation Energy. In 2002, John was a Partner and CEO of Edson Moore Healthcare Ventures, where he oversaw the acquisition of a portfolio of sixteen drug delivery investments from Elan Pharmaceuticals for US$148 million.

John is a graduate of Rutgers University, US, and brings a wealth of experience and strategic insight to his current roles.